VICT15 Jun 2011 14:41
Performance during the period
The VCT gained 3.3% over the 3 month period to 30 April 2011. This was a favourable result against the benchmark index (the FTSE AIM All-share Total Return) which ended the same period down 1.8%. The negative index performance reflects the beginning of the weakness in the commodities sector at the end of April due to concerns over the durability of the global economic recovery. Natural resource stocks have been the key driver behind AIM performance for over two years.
The main contributors to the VCT's performance were Lo-Q, which announced strong results confirming its impressive growth and development; Tasty, which posted good like-for-like sales figures against a difficult economic backdrop for a restaurant chain; IDOX, following the acquisition of a licensing management software business; and Symphony Environmental, following full year results. The most disappointing performer was AssetCo, which announced that it's recent fund raising had been insufficient to stem the cashflow pressures, and a serious fall-out between various stake-holders became public. The company continues to trade but we have exited this position. Tristel also disappointed the market with a substantial downgrade to profit expectations.
During the period, we completed qualifying deals in: Deltex Medical, a supplier of medical devices to monitor blood rate and flow during and after surgery, allowing fluid replacement to be optimised; Futura Medical, a developer of sexual health products that has signed three significant licensing deals with major distributors; and Microsaic, a designer of innovative mass spectrometry devices that are smaller, and quieter than their competitors' products, and will sell at about half the price. We also added to the non-qualifying portfolio, acquiring, amongst others, holdings in EROS International, an Indian media business; and OPG, an Indian power generator. We added to the VCT's holding in London Capital Group through participation in a placing at a valuation that we deemed to be compelling.
The turnover of the qualifying portfolio has now slowed as most of the small, high risk holdings have been exited. However, there were two further material qualifying sales during the period of ILX and the majority of the VCT's holding in Mediwatch. The limited liquidity afforded by small companies listed on AIM, particularly those with market capitalisations below £10m, made the qualifying portfolio reconstruction a slow process. However, we feel more confident about the remaining constituents, which have been supplemented with some new qualifying investments. In the non-qualifying portfolio, we sold NCC Group and Supergroup, both at acceptable profits, and took profits in Entertainment One and New Britain Palm Oil, although both remain material holdings.